Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.700
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
3.606
-0.095 (-2.55%)
After-hours: Dec 5, 2025, 5:58 PM EST
MRVI Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MRVI stock have an average target of 4.58, with a low estimate of 2.00 and a high estimate of 8.00. The average target predicts an increase of 23.78% from the current stock price of 3.70.
Analyst Consensus: Buy
* Price targets were last updated on Aug 12, 2025.
Analyst Ratings
The average analyst rating for MRVI stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +35.14% | Aug 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +35.14% | Aug 12, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +170.27% | May 13, 2025 |
| Baird | Baird | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -45.95% | May 13, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +35.14% | Mar 25, 2025 |
Financial Forecast
Revenue This Year
189.19M
from 259.19M
Decreased by -27.01%
Revenue Next Year
206.30M
from 189.19M
Increased by 9.04%
EPS This Year
-0.33
from -1.05
EPS Next Year
-0.21
from -0.33
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 200.6M | 229.7M | ||||
| Avg | 189.2M | 206.3M | ||||
| Low | 180.9M | 188.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -22.6% | 21.4% | ||||
| Avg | -27.0% | 9.0% | ||||
| Low | -30.2% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.30 | -0.16 | |||
| Avg | -0.33 | -0.21 | |||
| Low | -0.38 | -0.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.